
Sign up to save your podcasts
Or


Dr Tiffany Richards from The University of Texas MD Anderson Cancer Center in Houston discusses the current and emerging role of bispecific antibodies in the treatment of multiple myeloma.
NCPD information and select publications here.
By Research To Practice4.9
99 ratings
Dr Tiffany Richards from The University of Texas MD Anderson Cancer Center in Houston discusses the current and emerging role of bispecific antibodies in the treatment of multiple myeloma.
NCPD information and select publications here.

68 Listeners

31 Listeners

73 Listeners

14 Listeners

17 Listeners

4 Listeners

2 Listeners

12 Listeners

0 Listeners

120 Listeners